11 – 20 of 118
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Imbalance of the oxytocin-vasopressin system contributes to the neuropsychiatric phenotype in the BACHD mouse model of Huntington disease
(
- Contribution to journal › Article
-
Mark
Huntingtons sjukdom – kliniska prövningar inger nu optimism - Vanligaste formen av ärftlig neurodegenerativ sjukdom i västvärlden ger svåra symtom och förtidig död
(
- Contribution to journal › Article
- 2019
-
Mark
SIRT1 is increased in affected brain regions and hypothalamic metabolic pathways are altered in Huntington disease
(
- Contribution to journal › Article
-
Mark
Detailed assessment of hypothalamic damage in craniopharyngioma patients with obesity
(
- Contribution to journal › Article
-
Mark
The psychopharmacology of Huntington disease
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition
2018) In Proceedings of the National Academy of Sciences of the United States of America 115(37). p.8765-8774(
- Contribution to journal › Article
-
Mark
mHTT Seeding Activity : A Marker of Disease Progression and Neurotoxicity in Models of Huntington's Disease
(
- Contribution to journal › Article
-
Mark
Thermoregulatory disorders in Huntington disease
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Thermoregulation in amyotrophic lateral sclerosis
(
- Chapter in Book/Report/Conference proceeding › Book chapter